Hi, we’re Seer.

We believe everyone should be able to get answers to their most pressing health concerns as quickly as possible.

Our mission is to give people more control over their most valuable assets — their health and their time.

Pictured from left to right, Seer’s co-founders: Mark Cook, Dean Freestone and George Kenley.

We started Seer to solve accessibility challenges in neurodiagnostics.

Video-EEG-ECG testing is the undisputed gold standard for diagnosing and characterizing epilepsy and related conditions. A significant portion of the population will experience an event that requires testing to understand the cause and treatment pathway.

Today, there is a drastic unmet need for video-EEG-ECG testing globally. Limited access can result in years-long delays in getting answers and contributes to the 30% misdiagnosis rate in epilepsy, and one-third of people with epilepsy never get control of their seizures. This has created a dire situation for people experiencing seizures and spells.

My co-founders and I started Seer to solve these major issues. Seer is here to empower physicians and people living with epilepsy to make data-informed decisions that will enable them to live fuller, happier lives.

Dean Freestone
Co-Founder

As featured in

Shaking up a stagnant sector

Seer’s technologies are firsts of their kind. From hardware to software, and everything in between, we’re making meaningful progress for patient experiences and outcomes in this industry for the first time in decades.

Sense

Award-winning EEG-ECG wearable

WaterTabs®

Water-soluble electrode adhesive

Seizure cycles research

Breakthroughs in risk forecasting

Continent-scale proof of concept

Australia is Seer’s home market. Since 2017, we’ve helped more than 15,000 Australians reach accurate diagnosis, fast-tracking their pathway to effective condition management.

Through this process, we have diverted more than 246 years of inpatient hospital bed years to at-home diagnostic care, freeing up those beds for people who require medical treatments and interventions.

*Approximate figures representing the total number of long-term video-EEG-ECG studies in Australia since 2017

Built for the world

Right from the start, Seer’s vision has been to change how objective data for accurate diagnosis is collected. Our products and services have been developed from the ground up to make scaling neurodiagnostics in large-scale health systems possible.

With global offices in the United States, the United Kingdom, and Europe, Seer is uniquely positioned to open up access to critical diagnostic testing for hundreds of thousands of people.

Deep roots in research

Seer’s research team includes some of the world’s most distinguished figures in the neurology and epilepsy research communities, regularly collaborating with research leaders around the world.

Seer has published over 50 peer-reviewed papers, nearly 30 of which are part of the My Seizure Gauge Project which has been advancing the study of seizure cycles and seizure cycle tracking for several years.

Learn more about seizure cycle tracking.

Distinctive value to healthcare systems

Vertically integrated organization

Our data feedback loop enables hardware and software innovation at an unprecedented pace.

Expert clinical insights

We leverage the expertise of our scientists, epileptologists, and our community of people living with epilepsy to transform patient care.

Furthering epilepsy research

Seer’s researchers are award-winning experts in their field, collectively publishing over 50 papers in top-tier peer-reviewed journals.

Partner-first mentality

We’re not a traditional vendor. We partner with providers to solve the pressing issues in epilepsy care and deliver world-class services for their patients.